Rankings
▼
Calendar
MCK (McKesson Corporation) Stock Financials & Earnings | Market Cap Arena
MCK
McKesson Corporation
Mkt Cap
$115B
Healthcare
·
Medical - Distribution
·
🇺🇸 United States
·
NYSE
Revenue (TTM)
$398.0B
Net Income (TTM)
$4.3B
EPS (TTM)
$34.77
Free Cash Flow (TTM)
$10.1B
Gross Margin
3.4%
Op. Margin
1.3%
Net Margin
1.1%
FCF Margin
2.5%
P/S Ratio (TTM)
0.3x
P/E Ratio (TTM)
26.5x
YoY Rev Growth
+15.5%
Employees
—
Earnings Reports
▶
Q3 2026
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q4 23
$68.9B
$3.0B
$1.1B
Q1 24
$74.5B
$2.8B
$1.0B
Q2 24
$77.2B
$2.9B
$898M
Q3 24
$80.9B
$3.0B
$623M
Q4 24
$76.4B
$3.5B
$1.4B
Q1 25
$79.3B
$3.0B
$1.1B
Q2 25
$93.7B
$3.1B
$745M
Q3 25
$95.3B
$3.2B
$1.3B
Q4 25
$90.8B
$2.9B
$1.0B
Q1 26
$97.8B
$3.3B
$1.0B
Q2 26
$103.2B
$3.5B
$1.5B
Q3 26
$106.2B
$3.7B
$1.6B
marketcaparena.com
Revenue Breakdown
MCK
McKesson Corporation
Revenue Breakdown
Q3 2026
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q4 23
0.4x
32.3x
Q1 24
0.4x
30.7x
Q2 24
0.4x
33.0x
Q3 24
0.4x
38.4x
Q4 24
0.4x
38.3x
Q1 25
0.4x
38.9x
Q2 25
0.3x
45.4x
Q3 25
0.3x
40.7x
Q4 25
0.3x
34.9x
Q1 26
0.3x
36.4x
Q2 26
0.3x
28.5x
Q3 26
0.3x
26.5x
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q4 23
$3.3B
$3.1B
Q1 24
-$1.1B
-$1.2B
Q2 24
$965M
$825M
Q3 24
$254M
$100M
Q4 24
$4.1B
$3.9B
Q1 25
-$1.4B
-$1.5B
Q2 25
$2.1B
$1.9B
Q3 25
-$2.4B
-$2.6B
Q4 25
$7.7B
$7.5B
Q1 26
-$918M
-$1.0B
Q2 26
$2.4B
$2.5B
Q3 26
$1.2B
$1.1B
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q4 23
$182M
Q1 24
$124M
Q2 24
$140M
Q3 24
$154M
Q4 24
$269M
Q1 25
$167M
Q2 25
$218M
Q3 25
$196M
Q4 25
$278M
Q1 26
$111M
Q2 26
$111M
Q3 26
$108M
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q4 23
+4.2%
+3.8%
Q1 24
+10.9%
+11.1%
Q2 24
+10.1%
+10.6%
Q3 24
+14.8%
+15.8%
Q4 24
+10.8%
+10.6%
Q1 25
+6.4%
+6.5%
Q2 25
+21.3%
+21.7%
Q3 25
+17.8%
+17.1%
Q4 25
+18.9%
+19.7%
Q1 26
+23.4%
+23.7%
Q2 26
+10.1%
+9.4%
Q3 26
+11.4%
+11.2%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q4 23
$0
0.0%
Q1 24
$0
0.0%
Q2 24
$46M
0.1%
Q3 24
$45M
0.1%
Q4 24
$0
0.0%
Q1 25
$0
0.0%
Q2 25
$0
0.0%
Q3 25
$0
0.0%
Q4 25
$0
0.0%
Q1 26
$0
0.0%
Q2 26
$0
0.0%
Q3 26
$0
0.0%
marketcaparena.com
OpEx Breakdown
S&M
SG&A
Quarter
S&M
SG&A
Q4 23
—
$1.9B
Q1 24
—
$1.8B
Q2 24
—
$2.0B
Q3 24
—
$2.4B
Q4 24
—
$2.1B
Q1 25
—
$1.9B
Q2 25
—
$2.4B
Q3 25
—
$1.9B
Q4 25
—
$1.9B
Q1 26
$2.2B
—
Q2 26
$2.1B
—
marketcaparena.com
Revenue Segments
International Segment
Medical-Surgical Solutions Segment
Prescription Technology Solutions
U.S. Pharmaceutical Segment
North American Pharmaceutical Segment
Oncology And Multispecialty Segment
Prescription Technology Solutions Segment
Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment
Quarter
International Segment
Medical-Surgical Solutions Segment
Prescription Technology Solutions
U.S. Pharmaceutical Segment
North American Pharmaceutical Segment
Oncology And Multispecialty Segment
Prescription Technology Solutions Segment
Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment
Q4 23
$3.4B
$2.7B
$1.2B
$61.7B
—
—
—
—
Q1 24
$3.5B
$2.6B
$1.2B
$67.2B
—
—
—
—
Q2 24
$3.5B
$2.8B
$1.1B
$69.8B
—
—
—
—
Q3 24
$3.6B
$3.0B
$1.2B
$73.0B
—
—
—
—
Q4 24
$3.5B
$2.8B
$1.2B
$68.8B
—
—
—
—
Q1 25
$3.7B
$2.6B
$1.2B
$71.7B
—
—
—
—
Q2 25
$3.7B
$2.9B
$1.3B
$85.7B
—
—
—
—
Q3 25
$3.9B
$2.9B
$1.4B
$87.1B
—
—
—
—
Q4 25
$3.5B
$2.9B
$1.3B
$83.2B
—
—
—
—
Q1 26
$3.7B
$2.7B
$1.4B
$90.0B
—
—
—
—
Q2 26
—
$2.9B
—
—
$86.5B
$12.0B
$1.4B
$302M
Q3 26
—
$3.0B
—
—
$88.3B
$13.0B
$1.5B
$335M
marketcaparena.com
Revenue by Geography
Quarter
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q4 23
$4.7B
$0
$4.7B
Q1 24
$2.6B
$0
$2.6B
Q2 24
$2.5B
$0
$2.5B
Q3 24
$2.0B
$0
$2.0B
Q4 24
$4.6B
$0
$4.6B
Q1 25
$2.3B
$0
$2.3B
Q2 25
$2.5B
$0
$2.5B
Q3 25
$1.1B
$0
$1.1B
Q4 25
$5.7B
$0
$5.7B
Q1 26
$2.4B
$0
$2.4B
Q2 26
$4.1B
$0
$4.1B
Q3 26
$3.0B
$0
$3.0B
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q4 23
138M
-2.1%
Q1 24
137M
-1.0%
Q2 24
135M
-1.3%
Q3 24
133M
-1.1%
Q4 24
132M
-1.3%
Q1 25
131M
-0.7%
Q2 25
129M
-1.1%
Q3 25
127M
-2.1%
Q4 25
126M
-0.6%
Q1 26
126M
-0.3%
Q2 26
124M
-0.9%
Q3 26
124M
-0.6%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 14
$3M
43K
FY 15
$3M
70K
FY 16
$3M
68K
FY 17
$3M
78K
FY 18
$3M
78K
FY 19
$3M
80K
FY 20
$3M
80K
FY 21
$3M
76K
FY 22
$4M
75K
FY 23
$5M
51K
FY 24
$6M
51K
FY 25
$8M
45K
marketcaparena.com